Objective: The objective of this study was to set up a standard cost model for breast-cancer treatment to be able to complete a cost-effectiveness analysis of Herceptin®. This is a new biotechnological pharmaceutical developed by Genentech. Herceptin® is a humanized monoclonal antibody that...

Life is not just a matter of length but of depth and quality as well. The effect of treatment on quality of life (QoL) is important at all stages of the patient’s treatment. However, relatively little is known about the long-term evolution of QoL for breast cancer treated patients. To...

The public choice literature suggests that bureaucrats might join forces with specific pressure and industrial groups which advocate an expansion of health care activities. As a result, the ongoing process of bureaucratisation can be a driving force behind the overproduction of health care...

This study documents the cost of immediate and delayed DIEP flap breast reconstruction. Immediate reconstruction is more attractive from an economic perspective since it only requires one operation, one anaesthetic procedure and one recovery period in hospital. From the perspective of health...